122 related articles for article (PubMed ID: 25060327)
1. Distinct MR Imaging Features of Triple-Negative Breast Cancer with Brain Metastasis.
Yeh RH; Yu JC; Chu CH; Ho CL; Kao HW; Liao GS; Chen HW; Kao WY; Yu CP; Chao TY; Dai MS
J Neuroimaging; 2015; 25(3):474-81. PubMed ID: 25060327
[TBL] [Abstract][Full Text] [Related]
2. Research and progress in magnetic resonance imaging of triple-negative breast cancer.
Li J; Han X
Magn Reson Imaging; 2014 May; 32(4):392-6. PubMed ID: 24512798
[TBL] [Abstract][Full Text] [Related]
3. Limited overall survival in patients with brain metastases from triple negative breast cancer.
Morris PG; Murphy CG; Mallam D; Accordino M; Patil S; Howard J; Omuro A; Beal K; Seidman AD; Hudis CA; Fornier MN
Breast J; 2012; 18(4):345-50. PubMed ID: 22607041
[TBL] [Abstract][Full Text] [Related]
4. Evaluation with 3.0-T MR imaging: predicting the pathological response of triple-negative breast cancer treated with anthracycline and taxane neoadjuvant chemotherapy.
Kim MJ; Kim EK; Park S; Moon HJ; Kim SI; Park BW
Acta Radiol; 2015 Sep; 56(9):1069-77. PubMed ID: 25228161
[TBL] [Abstract][Full Text] [Related]
5. Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer.
Sun B; Huang Z; Wu S; Ding L; Shen G; Cha L; Wang J; Song S
Oncotarget; 2016 Nov; 7(45):74006-74014. PubMed ID: 27659537
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases after breast-conserving therapy and systemic therapy: incidence and characteristics by biologic subtype.
Arvold ND; Oh KS; Niemierko A; Taghian AG; Lin NU; Abi-Raad RF; Sreedhara M; Harris JR; Alexander BM
Breast Cancer Res Treat; 2012 Nov; 136(1):153-60. PubMed ID: 22968656
[TBL] [Abstract][Full Text] [Related]
7. Survival outcomes of breast cancer patients who receive neoadjuvant chemotherapy: association with dynamic contrast-enhanced MR imaging with computer-aided evaluation.
Yi A; Cho N; Im SA; Chang JM; Kim SJ; Moon HG; Han W; Park IA; Noh DY; Moon WK
Radiology; 2013 Sep; 268(3):662-72. PubMed ID: 23592770
[TBL] [Abstract][Full Text] [Related]
8. Prognosis prediction and risk factors for triple-negative breast cancer patients with brain metastasis: A population-based study.
Yang Y; Zhang L; Tian W; Li Y; Qin Q; Mao Y; Liu X; Hong J; Hu L; Zeng Q; Zhang Q; Zhao H
Cancer Med; 2023 Apr; 12(7):7951-7961. PubMed ID: 36629093
[TBL] [Abstract][Full Text] [Related]
9. Brain metastases in breast cancer: prognostic factors and management.
Lee SS; Ahn JH; Kim MK; Sym SJ; Gong G; Ahn SD; Kim SB; Kim WK
Breast Cancer Res Treat; 2008 Oct; 111(3):523-30. PubMed ID: 17990100
[TBL] [Abstract][Full Text] [Related]
10. Brain metastases from breast cancer.
Santos J; Arantes J; Carneiro E; Ferreira D; Silva SM; Palma de Sousa S; Arantes M
Clin Neurol Neurosurg; 2020 Oct; 197():106150. PubMed ID: 32920499
[TBL] [Abstract][Full Text] [Related]
11. Triple-negative breast cancer: correlation between MR imaging and pathologic findings.
Uematsu T; Kasami M; Yuen S
Radiology; 2009 Mar; 250(3):638-47. PubMed ID: 19244039
[TBL] [Abstract][Full Text] [Related]
12. Morphological and Semiquantitative Kinetic Analysis on Dynamic Contrast Enhanced MRI in Triple Negative Breast Cancer Patients.
Gigli S; Amabile MI; David E; De Luca A; Grippo C; Manganaro L; Monti M; Ballesio L
Acad Radiol; 2019 May; 26(5):620-625. PubMed ID: 30145205
[TBL] [Abstract][Full Text] [Related]
13. [A retrospective analysis of clinic-pathological characteristics and prognostic factor for 137 cases of breast cancer brain metastasis].
Gao YC; Liu H; Lu S; Zhuang XR; Wang YX; Wang T; Wu YY; Chen MX
Zhonghua Wai Ke Za Zhi; 2013 Jan; 51(1):30-4. PubMed ID: 23578424
[TBL] [Abstract][Full Text] [Related]
14. Whole brain radiotherapy for brain metastases from breast cancer: estimation of survival using two stratification systems.
Viani GA; Castilho MS; Salvajoli JV; Pellizzon AC; Novaes PE; Guimarães FS; Conte MA; Fogaroli RC
BMC Cancer; 2007 Mar; 7():53. PubMed ID: 17386108
[TBL] [Abstract][Full Text] [Related]
15. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry.
Riecke K; Müller V; Neunhöffer T; Park-Simon TW; Weide R; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Wuerstlein R; Denkert C; Decker T; Fehm T; Nekljudova V; Rey J; Loibl S; Laakmann E; Witzel I
ESMO Open; 2023 Jun; 8(3):101213. PubMed ID: 37075697
[TBL] [Abstract][Full Text] [Related]
16. Primary and secondary distant metastatic breast cancer: two sides of the same coin.
Güth U; Magaton I; Huang DJ; Fisher R; Schötzau A; Vetter M
Breast; 2014 Feb; 23(1):26-32. PubMed ID: 24215983
[TBL] [Abstract][Full Text] [Related]
17. Breast-conserving therapy for triple-negative breast cancer.
Gangi A; Chung A; Mirocha J; Liou DZ; Leong T; Giuliano AE
JAMA Surg; 2014 Mar; 149(3):252-8. PubMed ID: 24382582
[TBL] [Abstract][Full Text] [Related]
18. Clinical features and course of brain metastases in triple-negative breast cancer: comparison with human epidermal growth factor receptor 2-positive and other type at single institution in Korea.
Jang G; Lee SS; Ahn JH; Jung KH; Lee H; Gong G; Kim HH; Ahn SD; Son BH; Ahn SH; Kim SB
Breast Cancer Res Treat; 2011 Jul; 128(1):171-7. PubMed ID: 21519835
[TBL] [Abstract][Full Text] [Related]
19. Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.
Namba Y; Kijima T; Yokota S; Niinaka M; Kawamura S; Iwasaki T; Takeda Y; Kimura H; Okada T; Yamaguchi T; Nakagawa M; Okumura Y; Maeda H; Ito M
Clin Lung Cancer; 2004 Sep; 6(2):123-8. PubMed ID: 15476598
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
